Hi! Last day! We made it. Thanks to ALL who made the trip to SF for #ASTRO25!!

Thank you to everyone who made the trip to San Francisco for #ASTRO25! Watch this video from ASTRO President Neha Vapiwala, MD, FASTRO, who offers thank yous, reminders before we return home, and announces the theme for ASTRO 2026. See you in Boston next year for #ASTRO26!

One week to #ESMO25. An unprecedented ESMO conference. Seven positive press releases, anticipating the expansion of T-DXd to the curative setting, two Trop2 ADCs reaching first-line mTNBC, 2 novel ET-based combos, adjuvant CDK4/6i improving OS. See you in Berlin! #ESMOAmbassadors

Very concerned about this misleading article, IORT is not the answer x.com/gmorgenson/sta… Our recently published study showed that IORT is inferior to partial breast irradiation: pubmed.ncbi.nlm.nih.gov/40975735/ Follow the data: Sameer Keole Neha Vapiwala Rahul Tendulkar, MD #bcsm

Excited to share that my co-authored article on low-level laser therapy for reducing severe radiation-induced oral mucositis is now published online. I contributed to this work through our department's Quality of Life team. doi.org/10.1002/lsm.70…

We are ready for The Korean Society of Radiation Oncology Annual Conference!

Jeong Ha Lee, a resident physician of SMC Radiation Oncology made a presentation for proton beam therapy as a local ablative therapy in pancreatic cancer. Congrats!

SHARE trial compared 66 Gy in 33 fxs vs. 65 Gy in 26 fxs for salvage RT for biochemical recurrence after prostatectomy. The cohort has not yet matured for the primary outcome. Moderate hypoRT with 65 Gy was associated with increased GI toxicity. #ProstateCancer

Twoarc trial compared 50.4 Gy in 28 fxs vs. 33 Gy in 10 fxs in neoadjuvant CCRT for rectal cancer. This trial is recently published in Annals of Surgery #RectalCancer

🚨Important update from ProtecT #ProstateCancer trial after central pathology review 1️⃣ Which early PCa need treatment? Which do not? 2️⃣ For “bad” early PCa, do RP or RT prevent long-term (15y) metastasis? 🧵1/ OncoAlert UroToday.com PCF Science JAMA Oncology European Association of Urology (EAU) Amer. Urol. Assn.

This year's KOSRO Conference featured a seminar on ultra-hypofractionated RT, with JS Chang discussing breast cancer, H Nagar presenting on prostate cancer, and R Timmerman speaking about PULSAR. JeeSuk Chang Himanshu Nagar Robert Timmerman